Restricted evaluation. Any demo access granted by MediQAI Life Sciences Ltd is personal, limited, revocable and solely for the purpose approved in the applicant's request. Approval may be limited by user type, organisation, purpose, duration, functionality and environment.
Confidentiality
Non-public screens, functions, workflows, demonstrations, documentation, technical information and other material made available in a restricted environment are confidential evaluation material. You must protect them and must not disclose them to anyone who has not been separately authorised.
No copying, piracy or redistribution
You must not reproduce, republish, distribute, sell, sublicense or systematically capture restricted demo material. Screen recording, video recording, bulk screenshots or automated capture are prohibited unless MediQAI gives prior written permission.
No reverse engineering or competitive extraction
You must not attempt to discover or derive source code, prompts, algorithms, model orchestration, architecture, database structures, APIs, rules, security mechanisms or proprietary methods; bypass access controls; scrape or crawl restricted areas; use bots or automated testing; conduct unauthorised vulnerability testing; or use confidential aspects of the demonstration to clone or reproduce the product.
Credentials and scope
Credentials are personal and non-transferable. They may not be shared. Access to selected functions does not create any entitlement to the full Symbio TwinAI application, source code, datasets, documentation or future functionality.
Data restrictions
Do not enter real patient data, identifiable health information, confidential clinical records or third-party personal information into a demonstration unless the specific environment and processing have been expressly authorised in writing.
Intellectual property
All intellectual-property rights remain with MediQAI Life Sciences Ltd or its licensors. Demo access grants only a limited right to evaluate the authorised demonstration and grants no licence to exploit confidential or proprietary material.
Suspension and termination
MediQAI may suspend or terminate access where these terms are breached, supplied information is inaccurate, security is threatened or access is no longer authorised. These confidentiality and intellectual-property restrictions continue after access ends to the extent permitted by applicable law.
Approved access may also be subject to additional written terms appropriate to the organisation, purpose, environment and scope of evaluation.